Eli Lilly and Company (NYSE:LLY) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2026 Earnings Conference Call.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 23,299 | $21,429,447 | -1% | 3.71% |
| 2. | Lee Munder Capital Group Lee Munder | 21,057 | $19,367,597 | +5% | 1.15% |
| 3. | Ayrshire Capital Management John Nevin Jr. | 6,706 | $6,168,029 | -31% | 3.19% |
| 4. | RWC Asset Management Tord Stallvik (Ceo) | 772 | $710,062 | +3% | 0.03% |
| 5. | Bayforest Capital Theodoros Tsagaris | 87 | $80,020 | 0.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,116.69 | 2,737 | $3,056,369.58 | 91,896,978 | 2026-01-07 | Filing | |
| $1,115.76 | 2,210 | $2,465,831.81 | 91,899,715 | 2026-01-07 | Filing | |
| $1,114.37 | 4,342 | $4,838,603.22 | 91,901,925 | 2026-01-07 | Filing | |
| $1,113.77 | 9,053 | $10,082,968.86 | 91,906,267 | 2026-01-07 | Filing | |
| $1,112.43 | 4,652 | $5,175,038.32 | 91,915,320 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 91,896,978 | $84,524,083,455 | 100% | |
| 2. | 5,337,672 | $4,909,430,619 | 1.33% | |
| 3. | 1,865,688 | $1,714,586,637 | 0.9% | |
| 4. | 1,775,707 | $1,633,242,027 | 1.06% | |
| 5. | 1,616,304 | $1,486,627,929 | 1.56% |
News See All
Why Eli Lilly and Company (LLY) is One of the Best Drug Stocks to Buy According to Analysts
Eli Lilly and Company (NYSE:LLY) is one of the best drug stocks to buy according to analysts.
Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
9 Best Drug Stocks to Buy According to Analysts
On April 27, Jurrien Timmer, director of global macro at Fidelity Investments, appeared on CNBC to talk about the market and oil prices, and how necessary it is for oil prices to retreat from their highs...
12 Best Growth Stocks to Buy and Hold in 2026
On April 24, the S&P 500 and Nasdaq closed at all-time highs; however, the bigger story is what's driving them there and what's coming next.
Analysts Reiterate Bullish Outlook on Eli Lilly and Company (LLY) Following Kelonia Acquisition
This is a reaffirmation of the firm’s initiation of coverage on the pharmaceutical company in February, when it noted Eli Lilly’s strong market share in obesity drugs and added that the stock was ...
15 Best Big Name Stocks to Buy
The term refers to companies that are leading players in their industries and have a significant impact on the market.
Jim Cramer’s Week Ahead: 17 Stocks in Focus, Including Alphabet and Bloom Energy
In this article, we will look at Jim Cramer’s Mad Money game plan for the week ahead.
Eli Lilly and Company’s (LLY) Foundayo Gets Prescribed 3,707 Times in the US in Second Week of Launch, Reuters Reports
Eli Lilly and Company (NYSE:LLY) is one of the best low volatility stocks to invest in right now.
8 Best Low Volatility Stocks to Invest In Right Now
On April 23, Peter Boockvar, One Point BFG Wealth Partners CIO, appeared on CNBC’s ‘Fast Money’ to talk about the market dynamics.
Hedge Fund Resource Center